Back to the Top
This is with regards to the comparison of drug's PK/PD with different
route of administration. Is it acceptable to compare the
pharmacokinetics of drug at the respective ED50 dose (evaluated
through pharmacodynamic studies through each route of administration)
inspite of comparing at various doses.
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "PD comparison between route of administration" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (firstname.lastname@example.org)